2005Anthology of MedicineRequires access

Change an significance of vascular endothelial growth factor level in serum of patients with non-small cell lung cancer

Qiang Luo

Open publisher page 0 citations

Abstract

Objective To determine the serum vascular endothelial growth factor(VEGF) level in patients with non-small cell lung cance(NSCLC) and explore its diagnostic value.Methods 32 NSCLS patients,19 patients with lung benign tumor and 30 healthy control subjects were included in this study.Serum VEGF level was measured by sandwith ELISA.Results Serum VEGF level in NSCLC(16.27±2.32 μg/ml) was significantly higher than those of lung benign tumor(11.08±2.02 μg/ml) and those of healthy subjects(10.52±2.03 μg/ml)(P0.001).The serum VEGF level in NSCLC was closely related to P-TNM stages,lymph node metastasis status and cell differentiation grade(P0.001).Using the criterion of serum VEGF level14.58 μg/ml,the sensitivity and specificity of the diagucsis for NSCLC were 71.88% and 93.33%,respectively.Conclusion The level of serum VEGF could be considered as a useful biological indicator to evaluate invasion and metastasis of NSCLC.

About this research paper

What this paper is about

Objective To determine the serum vascular endothelial growth factor(VEGF) level in patients with non-small cell lung cance(NSCLC) and explore its diagnostic value.Methods 32 NSCLS patients,19 patients with lung benign tumor and 30 healthy control subjects were included in this study.Serum VEGF level was measured by sandwith ELISA.Results Serum VEGF level in NSCLC(16.27±2.32 μg/ml) was significantly higher than those of lung benign tumor(11.08±2.02 μg/ml) and those of healthy subjects(10.52±2.03 μg/ml)(P0.001).The serum VEGF level in NSCLC was closely related to P-TNM stages,lymph node metastasis status and cell differentiation grade(P0.001).Using the criterion of serum VEGF level14.58 μg/ml,the sensitivity and specificity of the diagucsis for NSCLC were 71.88% and 93.33%,respectively.Conclusion The level of serum VEGF could be considered as a useful biological indicator to evaluate invasion and metastasis of NSCLC.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To determine the serum vascular endothelial growth factor(VEGF) level in patients with non-small cell lung cance(NSCLC) and explore its diagnostic value.Methods 32 NSCLS patients,19 patients with lung benign tumor and 30 healthy control subjects were included in this study.Serum VEGF level was measured by sandwith ELISA.Results Serum VEGF level in NSCLC(16.27±2.32 μg/ml) was significantly higher than those of lung benign tumor(11.08±2.02 μg/ml) and those of healthy subjects(10.52±2.03 μg/ml)(P0.001).The serum VEGF level in NSCLC was closely related to P-TNM stages,lymph node metastasis status and cell differentiation grade(P0.001).Using the criterion of serum VEGF level14.58 μg/ml,the sensitivity and specificity of the diagucsis for NSCLC were 71.88% and 93.33%,respectively.Conclusion The level of serum VEGF could be considered as a useful biological indicator to evaluate invasion and metastasis of NSCLC.

Key concepts: Medicine, Lung cancer, Vascular endothelial growth factor, Internal medicine, Lung, VEGF receptors, Oncology, Metastasis

Related papers

Back to paper searchBrowse research topicsOriginal source
Change an significance of vascular endothelial growth factor level in serum of patients with non-small cell lung cancer — Research Paper | ScholarLens